170 related articles for article (PubMed ID: 16951204)
1. Mitogen-activated protein kinase phosphatase-1 is required for cisplatin resistance.
Wang Z; Xu J; Zhou JY; Liu Y; Wu GS
Cancer Res; 2006 Sep; 66(17):8870-7. PubMed ID: 16951204
[TBL] [Abstract][Full Text] [Related]
2. ERK-dependent MKP-1-mediated cisplatin resistance in human ovarian cancer cells.
Wang J; Zhou JY; Wu GS
Cancer Res; 2007 Dec; 67(24):11933-41. PubMed ID: 18089824
[TBL] [Abstract][Full Text] [Related]
3. The role of mitogen-activated protein kinase phosphatase-1 in oxidative damage-induced cell death.
Zhou JY; Liu Y; Wu GS
Cancer Res; 2006 May; 66(9):4888-94. PubMed ID: 16651445
[TBL] [Abstract][Full Text] [Related]
4. Mitogen-activated protein kinase phosphatase-1 is overexpressed in non-small cell lung cancer and is an independent predictor of outcome in patients.
Vicent S; Garayoa M; López-Picazo JM; Lozano MD; Toledo G; Thunnissen FB; Manzano RG; Montuenga LM
Clin Cancer Res; 2004 Jun; 10(11):3639-49. PubMed ID: 15173070
[TBL] [Abstract][Full Text] [Related]
5. Docosahexaenoic acid induces apoptosis in lung cancer cells by increasing MKP-1 and down-regulating p-ERK1/2 and p-p38 expression.
Serini S; Trombino S; Oliva F; Piccioni E; Monego G; Resci F; Boninsegna A; Picci N; Ranelletti FO; Calviello G
Apoptosis; 2008 Sep; 13(9):1172-83. PubMed ID: 18679798
[TBL] [Abstract][Full Text] [Related]
6. Mitogen-activated protein kinase phosphatase-1 in human breast cancer independently predicts prognosis and is repressed by doxorubicin.
Rojo F; González-Navarrete I; Bragado R; Dalmases A; Menéndez S; Cortes-Sempere M; Suárez C; Oliva C; Servitja S; Rodriguez-Fanjul V; Sánchez-Pérez I; Campas C; Corominas JM; Tusquets I; Bellosillo B; Serrano S; Perona R; Rovira A; Albanell J
Clin Cancer Res; 2009 May; 15(10):3530-9. PubMed ID: 19417026
[TBL] [Abstract][Full Text] [Related]
7. Evidence that mitogen-activated protein kinase phosphatase-1 induction by proteasome inhibitors plays an antiapoptotic role.
Small GW; Shi YY; Edmund NA; Somasundaram S; Moore DT; Orlowski RZ
Mol Pharmacol; 2004 Dec; 66(6):1478-90. PubMed ID: 15448190
[TBL] [Abstract][Full Text] [Related]
8. Mitogen-activated protein kinase phosphatase-1 is a mediator of breast cancer chemoresistance.
Small GW; Shi YY; Higgins LS; Orlowski RZ
Cancer Res; 2007 May; 67(9):4459-66. PubMed ID: 17483361
[TBL] [Abstract][Full Text] [Related]
9. Insulin resistance affects the cytoprotective effect of insulin in cardiomyocytes through an impairment of MAPK phosphatase-1 expression.
Morisco C; Marrone C; Trimarco V; Crispo S; Monti MG; Sadoshima J; Trimarco B
Cardiovasc Res; 2007 Dec; 76(3):453-64. PubMed ID: 17698050
[TBL] [Abstract][Full Text] [Related]
10. Mitogen-activated protein kinase phosphatase-1 modulated JNK activation is critical for apoptosis induced by inhibitor of epidermal growth factor receptor-tyrosine kinase.
Takeuchi K; Shin-ya T; Nishio K; Ito F
FEBS J; 2009 Mar; 276(5):1255-65. PubMed ID: 19175673
[TBL] [Abstract][Full Text] [Related]
11. MKP1/CL100 controls tumor growth and sensitivity to cisplatin in non-small-cell lung cancer.
Chattopadhyay S; Machado-Pinilla R; Manguan-García C; Belda-Iniesta C; Moratilla C; Cejas P; Fresno-Vara JA; de Castro-Carpeño J; Casado E; Nistal M; Gonzalez-Barón M; Perona R
Oncogene; 2006 Jun; 25(23):3335-45. PubMed ID: 16462770
[TBL] [Abstract][Full Text] [Related]
12. Glutamine protects mice from lethal endotoxic shock via a rapid induction of MAPK phosphatase-1.
Ko HM; Oh SH; Bang HS; Kang NI; Cho BH; Im SY; Lee HK
J Immunol; 2009 Jun; 182(12):7957-62. PubMed ID: 19494320
[TBL] [Abstract][Full Text] [Related]
13. Expression of kinase suppressor of Ras1 enhances cisplatin-induced extracellular signal-regulated kinase activation and cisplatin sensitivity.
Kim M; Yan Y; Kortum RL; Stoeger SM; Sgagias MK; Lee K; Lewis RE; Cowan KH
Cancer Res; 2005 May; 65(10):3986-92. PubMed ID: 15899786
[TBL] [Abstract][Full Text] [Related]
14. Possible involvement of mitogen-activated protein kinase phosphatase-1 (MKP-1) in thyrotropin-releasing hormone (TRH)-induced prolactin gene expression.
Oride A; Kanasaki H; Purwana IN; Miyazaki K
Biochem Biophys Res Commun; 2009 May; 382(4):663-7. PubMed ID: 19289102
[TBL] [Abstract][Full Text] [Related]
15. Curcumin attenuates ethanol-induced toxicity in HT22 hippocampal cells by activating mitogen-activated protein kinase phosphatase-1.
Pae HO; Jeong SO; Zheng M; Ha HY; Lee KM; Kim EC; Kim DH; Hwang SY; Chung HT
Neurosci Lett; 2009 Apr; 453(3):186-9. PubMed ID: 19429032
[TBL] [Abstract][Full Text] [Related]
16. Indomethacin induces apoptosis in 786-O renal cell carcinoma cells by activating mitogen-activated protein kinases and AKT.
Ou YC; Yang CR; Cheng CL; Raung SL; Hung YY; Chen CJ
Eur J Pharmacol; 2007 Jun; 563(1-3):49-60. PubMed ID: 17341418
[TBL] [Abstract][Full Text] [Related]
17. Activation of mitogen-activated protein kinases by cisplatin and their role in cisplatin-resistance.
Brozovic A; Osmak M
Cancer Lett; 2007 Jun; 251(1):1-16. PubMed ID: 17125914
[TBL] [Abstract][Full Text] [Related]
18. c-Jun NH2 terminal kinase activation and decreased expression of mitogen-activated protein kinase phosphatase-1 play important roles in invasion and angiogenesis of urothelial carcinomas.
Shimada K; Nakamura M; Ishida E; Higuchi T; Tanaka M; Ota I; Konishi N
Am J Pathol; 2007 Sep; 171(3):1003-12. PubMed ID: 17690186
[TBL] [Abstract][Full Text] [Related]
19. Sanguinarine induces apoptosis in A549 human lung cancer cells primarily via cellular glutathione depletion.
Jang BC; Park JG; Song DK; Baek WK; Yoo SK; Jung KH; Park GY; Lee TY; Suh SI
Toxicol In Vitro; 2009 Mar; 23(2):281-7. PubMed ID: 19135517
[TBL] [Abstract][Full Text] [Related]
20. Protoapigenone, a novel flavonoid, induces apoptosis in human prostate cancer cells through activation of p38 mitogen-activated protein kinase and c-Jun NH2-terminal kinase 1/2.
Chang HL; Wu YC; Su JH; Yeh YT; Yuan SS
J Pharmacol Exp Ther; 2008 Jun; 325(3):841-9. PubMed ID: 18337475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
